|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5938
|
|
pubmed:dateCreated |
1975-1-15
|
|
pubmed:abstractText |
Carcinoembryonic antigen (C.E.A.) estimation has been used in the preoperative assessment of colorectal carcinoma patients and has been shown to give a useful guide to the presence of metastatic disease and ultimately to a poor prognosis if the serum concentration is 100 ng/ml or more. C.E.A. has been shown to be a more reliable index of tumour spread than either clinical examination or serum alkaline phosphatase estimation. Raised C.E.A. levels of less than 100 ng/ml do not, however, necessarily imply a poor prognosis. Routine C.E.A. estimation may have a valuable role in the assessment of the colorectal cancer patient by identifying those likely to benefit from postoperative chemotherapy.The test has also been assessed in a group of patients attending cancer follow-up clinics after radical resection of a colorectal tumour. Raised C.E.A. occurred in most of those developing recurrent disease, and in several patients a rising C.E.A. level preceded clinical or biochemical evidence of recurrence. C.E.A. estimation is a superior guide and of clinical importance when applied to the follow-up of the colorectal cancer patient.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-13898554,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-4119105,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-4130471,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-4758660,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-4804277,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-5034298,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-5067755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-5071695,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-5077141,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-5077412,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-5288389,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4421372-6023032
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0007-1447
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
183-7
|
|
pubmed:dateRevised |
2010-10-26
|
|
pubmed:meshHeading |
pubmed-meshheading:4421372-Alkaline Phosphatase,
pubmed-meshheading:4421372-Carcinoembryonic Antigen,
pubmed-meshheading:4421372-Colonic Neoplasms,
pubmed-meshheading:4421372-Female,
pubmed-meshheading:4421372-Follow-Up Studies,
pubmed-meshheading:4421372-Humans,
pubmed-meshheading:4421372-Liver Neoplasms,
pubmed-meshheading:4421372-Neoplasm Metastasis,
pubmed-meshheading:4421372-Neoplasm Recurrence, Local,
pubmed-meshheading:4421372-Prognosis,
pubmed-meshheading:4421372-Radioimmunoassay,
pubmed-meshheading:4421372-Rectal Neoplasms,
pubmed-meshheading:4421372-Time Factors
|
|
pubmed:year |
1974
|
|
pubmed:articleTitle |
Carcinoembryonic antigen in management of colorectal carcinoma.
|
|
pubmed:publicationType |
Journal Article
|
